1. Home
  2. ZLAB vs STAA Comparison

ZLAB vs STAA Comparison

Compare ZLAB & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • STAA
  • Stock Information
  • Founded
  • ZLAB 2013
  • STAA 1982
  • Country
  • ZLAB China
  • STAA United States
  • Employees
  • ZLAB N/A
  • STAA N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • STAA Ophthalmic Goods
  • Sector
  • ZLAB Health Care
  • STAA Health Care
  • Exchange
  • ZLAB Nasdaq
  • STAA Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • STAA 850.9M
  • IPO Year
  • ZLAB 2017
  • STAA N/A
  • Fundamental
  • Price
  • ZLAB $35.19
  • STAA $17.29
  • Analyst Decision
  • ZLAB Buy
  • STAA Hold
  • Analyst Count
  • ZLAB 5
  • STAA 8
  • Target Price
  • ZLAB $54.28
  • STAA $27.17
  • AVG Volume (30 Days)
  • ZLAB 689.4K
  • STAA 743.0K
  • Earning Date
  • ZLAB 08-07-2025
  • STAA 08-06-2025
  • Dividend Yield
  • ZLAB N/A
  • STAA N/A
  • EPS Growth
  • ZLAB N/A
  • STAA N/A
  • EPS
  • ZLAB N/A
  • STAA N/A
  • Revenue
  • ZLAB $418,326,000.00
  • STAA $279,134,000.00
  • Revenue This Year
  • ZLAB $44.07
  • STAA N/A
  • Revenue Next Year
  • ZLAB $49.13
  • STAA $27.83
  • P/E Ratio
  • ZLAB N/A
  • STAA N/A
  • Revenue Growth
  • ZLAB 43.72
  • STAA N/A
  • 52 Week Low
  • ZLAB $16.01
  • STAA $13.50
  • 52 Week High
  • ZLAB $44.34
  • STAA $46.79
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 49.90
  • STAA 51.94
  • Support Level
  • ZLAB $32.31
  • STAA $17.11
  • Resistance Level
  • ZLAB $35.72
  • STAA $18.00
  • Average True Range (ATR)
  • ZLAB 1.10
  • STAA 0.65
  • MACD
  • ZLAB -0.34
  • STAA 0.10
  • Stochastic Oscillator
  • ZLAB 60.17
  • STAA 69.57

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.

Share on Social Networks: